Clinical Trial Update: A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating LSTA1 in combination with standard of care versus standard of care alone for patients with advanced cholangiocarcinoma or gallbladder c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• LSTA1

Snippet

Sponsor: Lisata Therapeutics, Inc. | Conditions: Cholangiocarcinoma, Gallbladder Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING